Alana Gerhardt

761 total citations
17 papers, 514 citations indexed

About

Alana Gerhardt is a scholar working on Infectious Diseases, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Alana Gerhardt has authored 17 papers receiving a total of 514 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Infectious Diseases, 8 papers in Molecular Biology and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Alana Gerhardt's work include Inhalation and Respiratory Drug Delivery (8 papers), SARS-CoV-2 and COVID-19 Research (7 papers) and Protein purification and stability (5 papers). Alana Gerhardt is often cited by papers focused on Inhalation and Respiratory Drug Delivery (8 papers), SARS-CoV-2 and COVID-19 Research (7 papers) and Protein purification and stability (5 papers). Alana Gerhardt collaborates with scholars based in United States, Canada and Belgium. Alana Gerhardt's co-authors include John F. Carpenter, Theodore W. Randolph, Jared S. Bee, Daniel K. Schwartz, Christopher B. Fox, Rachael A. Lewus, Bao Nguyen, Ryan M. Kramer, Michelle Archer and Corey Casper and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Controlled Release and Frontiers in Immunology.

In The Last Decade

Alana Gerhardt

13 papers receiving 500 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alana Gerhardt United States 10 342 120 112 86 76 17 514
Himanshu J. Sant United States 14 221 0.6× 305 2.5× 26 0.2× 30 0.3× 44 0.6× 52 726
Tim Menzen Germany 16 615 1.8× 180 1.5× 210 1.9× 22 0.3× 66 0.9× 48 755
Elisabeth Kastner United Kingdom 9 352 1.0× 326 2.7× 25 0.2× 23 0.3× 132 1.7× 11 753
Karoline Bechtold-Peters Switzerland 15 876 2.6× 262 2.2× 396 3.5× 158 1.8× 146 1.9× 38 1.1k
Tetsuo Torisu Japan 14 376 1.1× 112 0.9× 158 1.4× 17 0.2× 57 0.8× 37 502
Nida Alshraiedeh Jordan 9 83 0.2× 63 0.5× 133 1.2× 55 0.6× 22 0.3× 18 407
Timothy Wessler United States 12 177 0.5× 54 0.5× 53 0.5× 79 0.9× 135 1.8× 17 588
Carl M. Schoellhammer United States 12 137 0.4× 221 1.8× 35 0.3× 38 0.4× 22 0.3× 20 680
Stephen P. Cape United States 9 142 0.4× 66 0.6× 37 0.3× 107 1.2× 40 0.5× 9 399
Manakamana Khanal France 11 153 0.4× 114 0.9× 28 0.3× 41 0.5× 32 0.4× 15 455

Countries citing papers authored by Alana Gerhardt

Since Specialization
Citations

This map shows the geographic impact of Alana Gerhardt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alana Gerhardt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alana Gerhardt more than expected).

Fields of papers citing papers by Alana Gerhardt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alana Gerhardt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alana Gerhardt. The network helps show where Alana Gerhardt may publish in the future.

Co-authorship network of co-authors of Alana Gerhardt

This figure shows the co-authorship network connecting the top 25 collaborators of Alana Gerhardt. A scholar is included among the top collaborators of Alana Gerhardt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alana Gerhardt. Alana Gerhardt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Ordoubadi, Mani, Hui Wang, Alana Gerhardt, et al.. (2025). A Thermostable nasal spray dried COVID vaccine candidate. International Journal of Pharmaceutics. 685. 126240–126240.
2.
Jennewein, Madeleine F., Eric Lo, Nathan Cross, et al.. (2025). An intranasally- and intramuscularly-deliverable nanostructured lipid carrier-replicon RNA vaccine drives protective systemic and mucosal immunity. Journal of Controlled Release. 385. 114054–114054.
3.
Wang, Hui, Béla Reiz, Jing Zheng, et al.. (2025). Characterization of Spray-Dried Powders Using a Coated Alberta Idealized Nasal Inlet. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 38(1). 1–12. 3 indexed citations
4.
Kasal, Darshan N., Madeleine F. Jennewein, Nathan Cross, et al.. (2025). A bivalent self-amplifying RNA vaccine against yellow fever and Zika viruses. Frontiers in Immunology. 16. 1569454–1569454. 3 indexed citations
5.
Wang, Hui, Andrew R. Martin, Reinhard Vehring, et al.. (2025). A spray dried replicon vaccine platform for pandemic response. International Journal of Pharmaceutics. 680. 125777–125777.
6.
Pollet, Jeroen, Jessica A. White, Brian Keegan, et al.. (2024). Choice of adjuvant and antigen composition alters the immunogenic profile of a SARS-CoV-2 subunit vaccine. SHILAP Revista de lepidopterología. 4. 1342518–1342518.
7.
Archer, Michelle, Hong Liang, Dawn M. Fedor, et al.. (2023). Stressed stability and protective efficacy of lead lyophilized formulations of ID93+GLA-SE tuberculosis vaccine. Heliyon. 9(6). e17325–e17325. 1 indexed citations
8.
Gerhardt, Alana, Emily A. Voigt, Michelle Archer, et al.. (2022). A flexible, thermostable nanostructured lipid carrier platform for RNA vaccine delivery. Molecular Therapy — Methods & Clinical Development. 25. 205–214. 56 indexed citations
9.
Voigt, Emily A., Alana Gerhardt, Madeleine F. Jennewein, et al.. (2022). A self-amplifying RNA vaccine against COVID-19 with long-term room-temperature stability. npj Vaccines. 7(1). 136–136. 52 indexed citations
10.
Wang, Hui, Alana Gerhardt, Chris Press, et al.. (2021). Evaluation of the stability of a spray-dried tuberculosis vaccine candidate designed for dry powder respiratory delivery. Vaccine. 39(35). 5025–5036. 17 indexed citations
11.
Archer, Michelle, David Barona, Hui Wang, et al.. (2021). Microparticle encapsulation of a tuberculosis subunit vaccine candidate containing a nanoemulsion adjuvant via spray drying. European Journal of Pharmaceutics and Biopharmaceutics. 163. 23–37. 21 indexed citations
12.
Wang, Hui, Mani Ordoubadi, Nicholas B. Carrigy, et al.. (2020). Development of a formulation platform for a spray-dried, inhalable tuberculosis vaccine candidate. International Journal of Pharmaceutics. 593. 120121–120121. 40 indexed citations
13.
Alcaide, María L., Charlotte Mehlin Sørensen, Matthew G. McDonald, et al.. (2016). Biofouling resistance of boron-doped diamond neural stimulation electrodes is superior to titanium nitride electrodesin vivo. Journal of Neural Engineering. 13(5). 56011–56011. 19 indexed citations
14.
Gerhardt, Alana, Bao Nguyen, Rachael A. Lewus, John F. Carpenter, & Theodore W. Randolph. (2015). Effect of the Siliconization Method on Particle Generation in a Monoclonal Antibody Formulation in Pre-filled Syringes. Journal of Pharmaceutical Sciences. 104(5). 1601–1609. 42 indexed citations
15.
Gerhardt, Alana, Bao Nguyen, Rachael A. Lewus, et al.. (2015). Surfactant Effects on Particle Generation in Antibody Formulations in Pre-filled Syringes. Journal of Pharmaceutical Sciences. 104(12). 4056–4064. 46 indexed citations
16.
Gerhardt, Alana, et al.. (2014). Protein Aggregation and Particle Formation in Prefilled Glass Syringes. Journal of Pharmaceutical Sciences. 103(6). 1601–1612. 151 indexed citations
17.
Gerhardt, Alana, et al.. (2012). Ionic Strength Affects Tertiary Structure and Aggregation Propensity of a Monoclonal Antibody Adsorbed to Silicone Oil–Water Interfaces. Journal of Pharmaceutical Sciences. 102(2). 429–440. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Himanshu J. Sant Breakdown of academic impact, for papers by Tim Menzen Breakdown of academic impact, for papers by Elisabeth Kastner Breakdown of academic impact, for papers by Karoline Bechtold-Peters Breakdown of academic impact, for papers by Tetsuo Torisu Breakdown of academic impact, for papers by Nida Alshraiedeh Breakdown of academic impact, for papers by Timothy Wessler Breakdown of academic impact, for papers by Carl M. Schoellhammer Breakdown of academic impact, for papers by Stephen P. Cape Breakdown of academic impact, for papers by Manakamana Khanal
Rankless by CCL
2026